Abstract:The C282Y frequency shows a west to east decline from Ireland through the north of Europe. Vikings may have been involved in the spread of C282Y, but the mutation is probably older and may have been spread in Europe by earlier seafarers.
“…Molecular studies demonstrate that p.C282Y arose ~4000 years ago in the Neolithic Age [145,146] in Europe [147], possibly in Celtic people [148,149]. Although Vikings may have dispersed p.C282Y [146,149–151], especially in the late 8th-11th C, p.C282Y arose much earlier than the Viking era and thus may have also been spread in Europe by earlier seafarers [150]. Today, there are clines of decreasing p.C282Y frequency from Northwestern Europe to more eastern and southern regions of the continent [64,150].…”
The hemochromatosis gene HFE was discovered in 1996, more than a century after clinical and pathologic manifestations of hemochromatosis were reported. Linked to the major histocompatibility complex (MHC) on chromosome 6p, HFE encodes the MHC class I-like protein HFE that binds beta-2 microglobulin. HFE influences iron absorption by modulating the expression of hepcidin, the main controller of iron metabolism. Common HFE mutations account for ~90% of hemochromatosis phenotypes in whites of western European descent. We review HFE mapping and cloning, structure, promoters and controllers, and coding region mutations, HFE protein structure, cell and tissue expression and function, mouse Hfe knockouts and knockins, and HFE mutations in other mammals with iron overload. We describe the pertinence of HFE and HFE to mechanisms of iron homeostasis, the origin and fixation of HFE polymorphisms in European and other populations, and the genetic and biochemical basis of HFE hemochromatosis and iron overload.
“…Molecular studies demonstrate that p.C282Y arose ~4000 years ago in the Neolithic Age [145,146] in Europe [147], possibly in Celtic people [148,149]. Although Vikings may have dispersed p.C282Y [146,149–151], especially in the late 8th-11th C, p.C282Y arose much earlier than the Viking era and thus may have also been spread in Europe by earlier seafarers [150]. Today, there are clines of decreasing p.C282Y frequency from Northwestern Europe to more eastern and southern regions of the continent [64,150].…”
The hemochromatosis gene HFE was discovered in 1996, more than a century after clinical and pathologic manifestations of hemochromatosis were reported. Linked to the major histocompatibility complex (MHC) on chromosome 6p, HFE encodes the MHC class I-like protein HFE that binds beta-2 microglobulin. HFE influences iron absorption by modulating the expression of hepcidin, the main controller of iron metabolism. Common HFE mutations account for ~90% of hemochromatosis phenotypes in whites of western European descent. We review HFE mapping and cloning, structure, promoters and controllers, and coding region mutations, HFE protein structure, cell and tissue expression and function, mouse Hfe knockouts and knockins, and HFE mutations in other mammals with iron overload. We describe the pertinence of HFE and HFE to mechanisms of iron homeostasis, the origin and fixation of HFE polymorphisms in European and other populations, and the genetic and biochemical basis of HFE hemochromatosis and iron overload.
“…Highest frequencies are found in Ireland (mean 10.1%) and prevalence declines to near 0% in southeast Europe (Fairbanks, 2000; Olsson et al, 2011). Current analyses suggest that the temporal origin of the C282Y mutation, occurred 200 to 250 generations ago or at approximately 6,000 BP (4000 BCE) (Raha‐Chowdhury and Gruen, 2000) in central Europe (Symonette and Adams, 2011).…”
“…Although this haplotype is also described as a common HH ancestral haplotype in hemochromatosis populations in many northwestern European countries, particularly in Scandinavia [36], its appearance in Alabama HH patients is unlikely to be attributed predominantly to Norwegian or other Scandinavian founders because ancestry reports from these geographic areas of Europe are rare in Alabama hemochromatosis probands and population control subjects [39]. Nevertheless this haplotype could have a common ancestral Irish origin and be spread in Norway by the close contacts between Ireland and Scandinavia through the Vickings’ movements [35], [36]. In the case of Porto patients, the relative low diversity of HH haplotypes could be attributed to the particular demographic characteristics of the Portuguese population in the north region namely the unipolar mode of migration and the low rate of mobility from other regions [43].…”
Section: Discussionmentioning
confidence: 95%
“…The question of HLA haplotype conservation in HH has been a focus of scientific interest for a long time, and several interpretations about its role in the recent evolutionary history of chromosomes carrying the C282Y mutation have been largely discussed [3]–[7], [14], [17], [35], [36]. Besides the well described A*03–B*07 ancestral haplotype [3]–[7], also the A*01–B*08 haplotype is very long and resistant against recombination, and appears to be derived from a single ancestor [14], [17].…”
Hereditary Hemochromatosis (HH) is a recessively inherited disorder of iron overload occurring commonly in subjects homozygous for the C282Y mutation in HFE gene localized on chromosome 6p21.3 in linkage disequilibrium with the human leukocyte antigen (HLA)-A locus. Although its genetic homogeneity, the phenotypic expression is variable suggesting the presence of modifying factors. One such genetic factor, a SNP microhaplotype named A-A-T, was recently found to be associated with a more severe phenotype and also with low CD8+T-lymphocyte numbers. The present study aimed to test whether the predictive value of the A-A-T microhaplotype remained in other population settings. In this study of 304 HH patients from 3 geographically distant populations (Porto, Portugal 65; Alabama, USA 57; Nord-Trøndelag, Norway 182), the extended haplotypes involving A-A-T were studied in 608 chromosomes and the CD8+ T-lymphocyte numbers were determined in all subjects. Patients from Porto had a more severe phenotype than those from other settings. Patients with A-A-T seemed on average to have greater iron stores (p = 0.021), but significant differences were not confirmed in the 3 separate populations. Low CD8+ T-lymphocytes were associated with HLA-A*03-A-A-T in Porto and Alabama patients but not in the greater series from Nord-Trøndelag. Although A-A-T may signal a more severe iron phenotype, this study was unable to prove such an association in all population settings, precluding its use as a universal predictive marker of iron overload in HH. Interestingly, the association between A-A-T and CD8+ T-lymphocytes, which was confirmed in Porto and Alabama patients, was not observed in Nord-Trøndelag patients, showing that common HLA haplotypes like A*01–B*08 or A*03–B*07 segregating with HFE/C282Y in the three populations may carry different messages. These findings further strengthen the relevance of HH as a good disease model to search for novel candidate loci associated with the genetic transmission of CD8+ T-lymphocyte numbers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.